CD147-knockout cancer stem cells treated with docetaxel alone or in combination with methyl-β-cyclodextrin (MbCD) show increased p53 expression and decreased cyclin A levels, indicating that docetaxel-induced cell cycle arrest relies on proteins closely associated with CD147 (137). Here, BSG is linked to cancer.